HCPLive

Bone Loss Drugs Increase Stroke Risk in Patients with Cancer

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.

Article courtesy of http://www.onclive.com
 

Most Popular

Recommended Reading

As healthy adults age their motor response inhibition may become impaired, according to Ali Shoraka, MD, a Researcher Coordinator at the University of Florida in Gainesville, FL. The study is due to be presented in a poster session on Apr. 20 at the American Academy of Neurology meeting in Washington, DC.
Diagnosing Anti-N-methyl D-aspartate receptor (NMDAR) antibody encephalitis in adults differs from doing so in young children. Gait disturbance is a reliable sign, a Johns Hopkins team reports.
Autoimmune encephalitis is often fatal, but with prompt diagnosis and appropriate ICU care, many patients survive.
Contrary to common believe, Dengue Fever can be neuro-tropic, a team of researchers in Secunderabad, India found.
$vAR$